Ipsen Pharma

About the company

Ipsen is an international biopharmaceutical company engaged in scientific research and medicine development. Originating as a family company in France, it has developed an international research, development and commercial presence. Its focus is on specialist areas of treatment.

The company connects the search for new medicines with clinical research and delivery to patients. It develops its own research programmes and works with biotechnology companies and academic organisations, bringing internal expertise together with external scientific innovation.

Key areas of activity

Ipsen focuses on three therapeutic areas: oncology, rare disease and neuroscience. Oncology research addresses different tumour types, while the rare-disease area includes, among other conditions, rare liver and bone diseases. These specialist fields shape both its portfolio and its development priorities.

Portfolio development combines internal research, licensing and scientific partnerships. Clinical evidence and an understanding of patient needs are important parts of that work. The company gives particular attention to areas where existing treatment options are limited, with research activities extending across different stages of medicine development.

Partnership with Zeytun

Ipsen is among the strategic and commercial partners of Zeytun Pharmaceuticals. This cooperation forms part of our international partnership portfolio. For further information about the partnership and related products, please contact the Zeytun Pharmaceuticals team.